Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnosis and Management of Patent Foramen Ovale for Stroke Prevention: An Australian and New Zealand Consensus Statement Developed by a Modified Nominal Group Approach.

The Medical journal of Australia·2026
Same author

Aotearoa New Zealand's neurologist workforce: a 2024 analysis of demand, supply and projections.

BMJ neurology open·2026
Same author

The clinical association of left atrial appendage thrombus on CTA with functional outcome.

European stroke journal·2026
Same author

The clinical association of left atrial appendage thrombus on CTA with functional outcome.

European stroke journal·2025
Same author

Isolated leptomeningeal enhancement without cerebral microbleeds in biopsy-confirmed inflammatory cerebral amyloid angiopathy.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2024
Same author

Sex differences in stroke reperfusion therapy in Aotearoa (New Zealand).

Internal medicine journal·2024
Same journal

Reed diffusers: a potential cause of poisoning in young children in New Zealand.

The New Zealand medical journal·2026
Same journal

Stuffy nights: elevated bedroom carbon dioxide concentrations indicate inadequate ventilation in Wellington homes.

The New Zealand medical journal·2026
Same journal

Cautionary tale of how sodium polystyrene sulfonate caused gut necrosis: a case report.

The New Zealand medical journal·2026
Same journal

Emergency lateral canthotomy and cantholysis for acute globe subluxation.

The New Zealand medical journal·2026
Same journal

Liberation of an incarcerated tibialis posterior tendon following a posterior malleolar ankle fracture: a case report.

The New Zealand medical journal·2026
Same journal

Implementing a cultural safety training plan across medical colleges in Aotearoa New Zealand-looking back, and looking forward.

The New Zealand medical journal·2026
See all related articles

Related Experiment Video

Updated: Jun 19, 2026

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
16:02

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

Published on: February 10, 2023

Phenytoin toxicity and thyroid dysfunction.

Tobias Betteridge1, John Fink

  • 1Department of Emergency Medicine, Christchurch Hospital, Private Bag 4710, Christchurch, New Zealand. tobias.betteridge@cdhb.govt.nz

The New Zealand Medical Journal
|October 24, 2009
PubMed
Summary
This summary is machine-generated.

Phenytoin toxicity can cause profound hypothyroidism, even with adequate thyroid hormone replacement. Normalizing phenytoin levels restored normal thyroid function in a patient with epilepsy.

More Related Videos

Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity
09:32

Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity

Published on: October 17, 2025

Related Experiment Videos

Last Updated: Jun 19, 2026

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
16:02

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

Published on: February 10, 2023

Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity
09:32

Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity

Published on: October 17, 2025

Area of Science:

  • Clinical Neurology
  • Pharmacology
  • Endocrinology

Background:

  • Epilepsy management often involves antiepileptic drugs like phenytoin.
  • Thyroid dysfunction can complicate patient care and drug management.
  • Drug interactions can significantly impact therapeutic outcomes.

Observation:

  • A patient with epilepsy presented with symptoms of phenytoin toxicity, including ataxia and slurred speech.
  • Elevated phenytoin levels (170 mmol/L) were detected.
  • The patient was also found to be profoundly hypothyroid despite thyroid hormone replacement therapy.

Findings:

  • Phenytoin withdrawal led to the normalization of phenytoin levels.
  • Normalization of phenytoin levels was associated with the resolution of hypothyroidism and return to euthyroidism.
  • This suggests a significant interaction between phenytoin and thyroid function or its replacement therapy.

Implications:

  • Clinicians should consider thyroid function monitoring in patients on phenytoin, especially those with unexplained thyroid abnormalities.
  • Phenytoin may interfere with thyroid hormone replacement therapy, necessitating dose adjustments.
  • Understanding this drug interaction is crucial for optimizing epilepsy and endocrine management.